- Home
- BRCB vs ARCT Comparison
BRCB vs ARCT Comparison
Compare BRCB & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BRCB | ARCT |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.7M | 163.4M |
| IPO Year | 2025 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BRCB | ARCT |
|---|---|---|
| Price | $7.28 | $12.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 13 |
| Target Price | $12.00 | ★ $23.20 |
| AVG Volume (30 Days) | 297.0K | ★ 785.2K |
| Earning Date | 11-10-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $200,321,000.00 | $82,031,000.00 |
| Revenue This Year | $27.39 | N/A |
| Revenue Next Year | $24.41 | $58.72 |
| P/E Ratio | $91.88 | ★ N/A |
| Revenue Growth | ★ 24.49 | N/A |
| 52 Week Low | $6.11 | $5.50 |
| 52 Week High | $26.45 | $24.14 |
Technical Indicators
Market Signals| Indicator | BRCB | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 41.11 | 45.30 |
| Support Level | $6.89 | $6.47 |
| Resistance Level | $8.67 | $17.85 |
| Average True Range (ATR) | 0.35 | 1.34 |
| MACD | 0.01 | -0.40 |
| Stochastic Oscillator | 50.56 | 4.28 |
Price Performance
Historical ComparisonAbout BRCB Black Rock Coffee Bar Inc.
Black Rock Coffee Bar Inc is an operator of guest-centric, drive-thru coffee bars offering premium caffeinated beverages and an elevated in-store experience crafted by its engaging baristas. The company offers wide variety of coffee from classic espresso-based drinks such as Lattes, Americanos, and Cappuccinos, as well as signature creations like the Caramel Blondie, Mexican Mocha, and Blackout. It offers a variety of savory and sweet items, including breakfast burritos, sausage cheddar sandwiches, banana bread, and glazed donut holes.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.